Abuse-deterrent pharmaceutical compositions of opiods and...

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S464000, C424S451000, C424S502000

Reexamination Certificate

active

07399488

ABSTRACT:
An abuse-deterrent pharmaceutical composition has been developed to reduce the likelihood of improper administration of drugs, especially drugs such as opiods. In the preferred embodiment, a drug is modified to increase its lipophilicity. In preferred embodiments the modified drug is homogeneously dispersed within microparticles composed of a material that is either slowly soluble or not soluble in water. In some embodiments the drug containing microparticles or drug particles are coated with one or more coating layers, where at least one coating is water insoluble and preferably organic solvent insoluble, but enzymatically degradable by enzymes present in the human gastrointestinal tract. The abuse-deterrent composition retards the release of drug, even if the physical integrity of the formulation is compromised (for example, by chopping with a blade or crushing) and the resulting material is placed in water, snorted, or swallowed. However, when administered as directed, the drug is slowly released from the composition as the composition is broken down or dissolved gradually within the GI tract by a combination of enzymatic degradation, surfactant action of bile acids, and mechanical erosion.

REFERENCES:
patent: 3773955 (1973-11-01), Pachter
patent: 3966940 (1976-06-01), Pachter et al.
patent: 3980766 (1976-09-01), Shaw et al.
patent: 4070494 (1978-01-01), Hoffmeister et al.
patent: 4457933 (1984-07-01), Gordon et al.
patent: 5508042 (1996-04-01), Oshlack et al.
patent: 5756483 (1998-05-01), Merkus
patent: 5849240 (1998-12-01), Miller et al.
patent: 5891471 (1999-04-01), Miller et al.
patent: 5952005 (1999-09-01), Olsson et al.
patent: 5958452 (1999-09-01), Oshlack et al.
patent: 5965161 (1999-10-01), Oshlack et al.
patent: 5965163 (1999-10-01), Miller et al.
patent: 5968551 (1999-10-01), Oshlack et al.
patent: 6048736 (2000-04-01), Kosak
patent: 6068855 (2000-05-01), Leslie et al.
patent: 6103261 (2000-08-01), Chasin et al.
patent: 6162467 (2000-12-01), Miller et al.
patent: 6261599 (2001-07-01), Oshlack et al.
patent: 6277384 (2001-08-01), Kaiko et al.
patent: 6294195 (2001-09-01), Oshlack et al.
patent: 6309668 (2001-10-01), Bastin et al.
patent: 6310072 (2001-10-01), Smith et al.
patent: 6335033 (2002-01-01), Oshlack et al.
patent: 6375957 (2002-04-01), Kaiko et al.
patent: 6475494 (2002-11-01), Kaiko et al.
patent: 6696088 (2004-02-01), Oshlack et al.
patent: 6706281 (2004-03-01), Oshlack et al.
patent: 6723343 (2004-04-01), Kugelmann
patent: 6743442 (2004-06-01), Oshlack et al.
patent: 2002/0081333 (2002-06-01), Oshlack et al.
patent: 2006/0104909 (2006-05-01), Vaghefi et al.
Cortesi, et al., “Sugar cross-linked gelatin for controlled release: microspheres and disks,”Biomaterials19:1641-1649 (1998).
Gennaro, ed.,Remington: The Science and Practice of Pharmacology, 20thed., Lipincott: Baltimore, MD, pp. 704-706 (2000).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Abuse-deterrent pharmaceutical compositions of opiods and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Abuse-deterrent pharmaceutical compositions of opiods and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Abuse-deterrent pharmaceutical compositions of opiods and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2795232

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.